Serum Institute of India

Pune district receives 1.13 lakh doses of Covishield

10:53 pm January 13, 2021

Pune : Pune district received over 1.13lakh doses of the Covishield vaccine against coronavirus on Wednesday, officials said. The transportation of the vaccine, manufactured at Serum Institute of India (SII) here, began on Tuesday morning. District Collector Rajesh Deshmukh said all the preparations are completed as inoculation drive will begin on January 16. The number […]

Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech set to dispatch first consignment of Covaxin

2:55 pm January 12, 2021

Hyderabad : Bharat Biotech, which has received Emergency Use Authorisation approval from the Drug Controller General of India for its COVID-19 vaccine Covaxin,is set to dispatch it from the Rajiv Gandhi International Airport here on Tuesday evening, a senior official of the Airports cargo division said. ”Today we have received the first consignment of vaccines […]

Bharat Biotech, Serum Institute declare truce, pledge for smooth roll out of COVID-19 vaccines

9:23 pm January 5, 2021

Hyderabad : After their ugly public spat, Serum Institute of India and Bharat Biotech on Tuesday buried the hatchet and issued a joint statement saying they will work together to develop, manufacture and supply the COVID-19 vaccines in the country and globally. In the statement posted on their respective twitter accounts, the companies said Serum […]

In process to apply for emergency use licensure for COVID-19 vaccine: Adar Poonawalla

10:23 pm November 28, 2020

New Delhi: Vaccine major Serum Institute of India (SII) on Saturday said it is in the process of applying for an emergency use licensure for the AstraZeneca-Oxford’s COVID-19 vaccine candidate in India in the next two weeks. Addressing a virtual press conference on the visit of Prime Minister Narendra Modi to the company’s Pune facility, Serum Institute […]

Delighted at AstraZeneca vaccine’s effectiveness: Adar Poonawalla

8:41 pm November 23, 2020

Mumbai: Serum Institute of India (SII) CEO Adar Poonawalla on Monday expressed happiness at pharma major AstraZeneca’s announcement that its COVID-19 vaccine candidate has been found to be 70 per cent effective on average. AstraZeneca said one dosing regimen showed vaccine efficacy of 90 per cent when the vaccine was given as a half-dose followed by a […]